Analyst: St. Jude Medical's Q2 results could signal ICD rebound

St. Jude Medical's 2nd-quarter results, including a 2% gain for its implantable cardiac defibrillator business, could signal a rebound for the ICD sector overall, according to Leerink Partners.

St. Jude Medical

News Well, MassDevice.com Earnings Roundup, Cardiac Rhythm Management, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1snZtrl